<DOC>
	<DOCNO>NCT00279214</DOCNO>
	<brief_summary>The study evaluate vasopressor requirement , hemodynamic response measure tissue perfusion patient septic shock receive infusion drotrecogin alfa ( activate ) compare patient receive drotrecogin alfa ( activate ) .</brief_summary>
	<brief_title>Hemodynamic Perfusion Response Drotrecogin Alfa ( Activated ) Patients With Septic Shock</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Drotrecogin alfa activate</mesh_term>
	<mesh_term>Protein C</mesh_term>
	<criteria>Inclusion : 18 year age old diagnosis septic shock presence pulmonary artery catheter ( central venous catheter ) require vasopressor support despite adequate fluid resuscitation intravenous steroid administer septic shock , except patient test responder corticotropin stimulation test , patient receive steroid due clinical judgment treat physician , base alternate assessment ( e.g . normal baseline cortisol ) . Exclusion : Onset firstsepsis induce organ dysfunction great 24 hour time inform consent Baseline measurement pulmonary artery occlusive pressure ( PAOP ) &lt; 12 mmHg central venous pressure ( CVP ) &lt; 8 mmHg Patient require continuous oxygen therapy facemask The presence advance directive withhold lifesustaining treatment , exception directive withhold chest compression Have receive treatment within last 30 day drug receive regulatory approval indication time study entry Weight &gt; 200 kg Are moribund ( expect survive 24 hour ) Are pregnant lactate milk ingest infant ( pregnancy status must verify urine serum test ) Have complete write informed consent sign patient patient 's legal representative .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
</DOC>